Top

Published in:

01-06-2015 | Original Article

Significant relationship between preoperative serum concentration of anti-heat shock protein 70 antibody and postoperative morbidity in patients with esophageal cancer

Authors: M. Nakajima, MD, PhD, FACS, H. Kato, MD, PhD, FACS, M. Sakai, MD, PhD, A. Sano, MD, PhD, T. Miyazaki, MD, PhD, FACS, M. Sohda, MD, PhD, T. Inose, MD, PhD, T. Yokobori, MD, PhD, N. Tanaka, MD, PhD, S. Suzuki, MD, N. Masuda, MD, PhD, M. Fukuchi, MD, PhD, H. Kuwano, MD, PhD, FACS

Published in: European Surgery | Issue 3/2015

Summary

Background

Heat shock protein 70 is a molecular chaperone important in host responses to stress, including infection, injury, oxidative damage, hypoxia, and thermal stress. This study analyzed the correlation between preoperative serum concentrations of anti-HPS70 antibody and postoperative morbidity in patients with esophageal cancer.

Materials and methods

Serum samples were obtained preoperatively from 50 esophageal carcinoma patients (46 men and 4 women) who underwent potentially curative surgery without preoperative therapy. Serum anti-HSP70 antibody concentrations were measured by enzyme-linked immunosorbent assays.

Results

The mean concentration of anti-HSP70 antibody was 187.0 μg/mL. When patients were dichotomized relative to this cutoff, we observed no significant relationships between perioperative inflammatory markers (maximum body temperature, white blood cell count and C-reactive protein concentration) and anti-HSP70 antibody concentration. The incidence of postoperative complications was significantly lower in patients with anti-HSP ≥ 187.0 μg/mL than < 187.0 μg/mL (p = 0.0336).

Conclusions

Preoperative serum concentration of anti-HSP70 antibody was significantly related to postoperative morbidities in patients with esophageal cancer.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN. 2008. Int J Cancer. 2010;127(12):2893–917.PubMedCrossRef

Sharaiha RZ, Halazun KJ, Mirza F, et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol. 2011;18(12):3362–9.PubMedCentralPubMedCrossRef

Biere SS, Maas KW, Cuesta MA, van der Peet DL. Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg. 2011;28(1):29–35.PubMedCrossRef

Glatz T, Marjanovic G, Zirlik K, et al. Surgical treatment of esophageal cancer: evolution of management and prognosis over the last 3 decades. Chirurg. 2014 ([Epub ahead of print] German).

Benedix F, Dalicho SF, Stübs P, et al. Evidence base for minimally invasive esophagectomy for esophageal cancer. Chirurg. 2014;85(8):668–74 (German).PubMedCrossRef

Hoeppner J, Marjanovic G, Glatz T, et al. Hybrid laparoscopic thoracotomic esophagectomy with intrathoracic esophagogastric anastomosis. Chirurg. 2014;85(7):628–35 (German).PubMedCrossRef

Evans CG, Chang L, Gestwicki JE. Heat shock protein 70 (HSP70) as an emerging drug target. J Med Chem. 2010;53(12):4585–602.PubMedCentralPubMedCrossRef

Vega VL, Rodríguez-Silva M, Frey T, et al. HSP70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J Immunol. 2008;180(6):4299–307.PubMedCrossRef

Nakajima M, Kuwano H, Miyazaki T, Masuda N, Kato H. Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. Cancer Lett. 2002;178(1):99–106.PubMedCrossRef

10.

Nakajima M, Kato H, Miyazaki T, et al. Tumor immune systems in esophageal cancer with special reference to heat-shock protein 70 and humoral immunity. Anticancer Res. 2009;29(5):1595–606.PubMed

11.

Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle. 2006;5(22):2592–601.PubMedCrossRef

12.

Jäättelä M, Wissing D. Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection. J Exp Med. 1993;177(1):231–6.PubMedCrossRef

13.

De Maio A. Heat shock proteins: facts, thoughts, and dreams. Shock. 1999;11(1):1–12.PubMedCrossRef

14.

Ran R, Lu A, Zhang L, et al. HSP70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes Dev. 2004;18(12):1466–81.PubMedCentralPubMedCrossRef

15.

Park KJ, Gaynor RB, Kwak YT. Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation. J Biol Chem. 2003;278(37):35272–8.PubMedCrossRef

16.

Saito K, Dai Y, Ohtsuka K. Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cells. Exp Cell Res. 2005;310(1):229–36.PubMedCrossRef

17.

Clayton A, Turkes A, Navabi H, Manson MD, Tabi Z. Induction of heat shock proteins in B-cell exosomes. J Cell Sci. 2005;118(Pt 16):3631–8.PubMedCrossRef

18.

Asea A, Kraeft SK, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6(4):435–42.PubMedCrossRef

19.

Panjwani NN, Popova L, Srivastava PK. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J Immunol. 2002;168(6):2997–3003.PubMedCrossRef

20.

Lehner T, Bergmeier LA, Wang Y, et al. Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol. 2000;30(2):594–603.PubMedCrossRef

21.

Pan PJ, Chan RC, Yang AH, Chou CL, Cheng YF, Chiu JL. Protective effects of preconditioned local somatothermal stimulation on neuromuscular plasticity against ischemia—reperfusion injury in rats. J Orthop Res. 2008;26(12):1670–4.PubMedCrossRef

22.

Jones Q, Voegeli TS, Li G, Chen Y, Currie RW. Heat shock proteins protect against ischemia and inflammation through multiple mechanisms. Inflamm Allergy Drug Targets. 2011;10(4):247–59.PubMedCrossRef

23.

St Rammos K, Koullias GJ, Hassan MO, et al. Low preoperative HSP70 atrial myocardial levels correlate significantly with high incidence of postoperative atrial fibrillation after cardiac surgery. Cardiovasc Surg. 2002; 10(3): 228–32.CrossRef

24.

Newkirk MM, Mitchell S, Procino M, et al. Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung disease. Eur J Immunol. 2012;42(4):1051–61.PubMedCrossRef

25.

Helgeland G, Petzold A, Hoff JM, Gilhus NE, Plant GT, Romi FR. Anti-heat shock protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome. J Neuroimmunol. 2010;225(1–2):180–3.PubMedCrossRef

26.

Zhang X, Xu Z, Zhou L, et al. Plasma levels of HSP70 and anti-HSP70 antibody predict risk of acute coronary syndrome. Cell Stress Chaperones. 2010;15(5):675–86.PubMedCentralPubMedCrossRef

27.

Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.PubMedCrossRef

28.

Biere SS, Maas KW, Cuesta MA, van der Peet DL. Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg. 2011;28(1):29–35.PubMedCrossRef

29.

Shiozaki A, Fujiwara H, Okamura H, et al. Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett. 2012;3(4):907–12.PubMedCentralPubMed

30.

Aminian A, Panahi N, Mirsharifi R, et al. Predictors and outcome of cervical anastomotic leakage after esophageal cancer surgery. J Cancer Res Ther. 2011; 7(4): 448–53.PubMedCrossRef

31.

Radons J, Mulfhoff G. Immunostimulatory functions of membrane-bound and exported heat shock protein 70. Exerc Immunol Rev. 2005;11:17–33.PubMed

32.

Michelet P, Journo XBD, Roch A, et al. Perioperative risk factors for anastomotic leakage after esophagectomy. Chest. 2005;128(5):3461–6.PubMedCrossRef

33.

Miyazaki T, Kuwano H, Kato H, Yoshikawa M, Ojima H, Tsukada K. Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy. World J Surg. 2002;26(11):1319–23.PubMedCrossRef

34.

Ikeda Y, Niimi M, Kan S, et al. Clinical significance of tissue blood flow during esophagectomy by laser Doppler flowmetry. J Thorac Cardiovasc Surg. 2001;122(6):1101–6.PubMedCrossRef

35.

Kimura Y, Yamada K, Sakai T, et al. The regulatory role of heat shock protein 70-reactive CD4 + T cells during rat listeriosis. Int Immunol. 1998;10(2):117–30.PubMedCrossRef

36.

Tanaka S, Kimura Y, Mitani A, et al. Activation of T cell recognizing an epitope of heat shock protein 70 can protect against rat adjuvant arthritis. J Immunol. 1999;163(10):5560–5.PubMed

37.

Paliwal PK, Bansal A, Sagi SS, Sairam M. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection. Vaccine. 2011;29(38):6532–9.PubMedCrossRef

38.

Fujibayashi T, Hashimoto N, Jijiwa M, Hasegawa Y, Kojima T, Ishiguro N. Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model. BMC Pulm Med. 2009; 9: 45.PubMedCentralPubMedCrossRef

39.

Yanaka A, Zhang S, Sato D, et al. Geranylgeranylacetone protects the human gastric mucosa from diclofenac-induced injury via induction of heat shock protein 70. Digestion. 2007;75(2–3):148–55.PubMedCrossRef

40.

Yu WY, Chuang TF, Guichard C, et al. Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model. Vaccine. 2011;29(18):3489–500.PubMedCrossRef

41.

Chen W, Lin Y, Liao C, Hsieh S. Modulatory effects of the human heat shock protein 70 on DNA vaccination. J Biomed Sci. 2000;7(5):412–9.PubMedCrossRef

Title: Significant relationship between preoperative serum concentration of anti-heat shock protein 70 antibody and postoperative morbidity in patients with esophageal cancer
Authors: M. Nakajima, MD, PhD, FACS
H. Kato, MD, PhD, FACS
M. Sakai, MD, PhD
A. Sano, MD, PhD
T. Miyazaki, MD, PhD, FACS
M. Sohda, MD, PhD
T. Inose, MD, PhD
T. Yokobori, MD, PhD
N. Tanaka, MD, PhD
S. Suzuki, MD
N. Masuda, MD, PhD
M. Fukuchi, MD, PhD
H. Kuwano, MD, PhD, FACS
Publication date: 01-06-2015
Publisher: Springer Vienna
Published in: European Surgery / Issue 3/2015
Print ISSN: 1682-8631
Electronic ISSN: 1682-4016
DOI: https://doi.org/10.1007/s10353-015-0317-9

At a glance: The STEP trials

Springer Medicine

Significant relationship between preoperative serum concentration of anti-heat shock protein 70 antibody and postoperative morbidity in patients with esophageal cancer

Summary

Background

Materials and methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Summary

Background

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2015

Surgical intervention does not affect short-term plasma citrulline levels in infants: implications for citrulline as a marker of postoperative intestinal complications

Long-term follow-up of patients diagnosed with nonspecific abdominal pain (NSAP): identification of pathology as a possible cause for NSAP

Pathophysiology of airway obstruction caused by wound hematoma after thyroidectomy: an ex vivo study

Antecolic anastomosis and delayed gastric emptying: still a benefit in patients without intra-abdominal complications?

Magnetic resonance visible 3-D funnel meshes for laparoscopic parastomal hernia prevention and treatment

Liposarcoma with lymph node spread: a case presentation and a systematic review of the literature